Skip to main content
. 2017 Dec 12;13:2637–2658. doi: 10.3762/bjoc.13.262

Figure 5.

Figure 5

Bioactivities of pentapeptide analogues based on the relative maximum agonistic activity at 10 nM of the compound to 1 μM kisspeptin-10 (%). 100% = maximum agonistic activity at 1 μm kisspeptin-10.